Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the Breast.

Zhang H, Moisini I, Ajabnoor RM, Turner BM, D'aguiar M, Cai X, Gao S, Yang Q, Wang X, Schiffhauer L, Hicks DG.

Am J Clin Pathol. 2019 Nov 30. pii: aqz194. doi: 10.1093/ajcp/aqz194. [Epub ahead of print]

PMID:
31786600
2.

A Comparison of Hysterectomies for Bleeding With Hysterectomies for Pain.

Turner BM, Cramer SF, Heller DS.

Int J Surg Pathol. 2019 Oct 15:1066896919879980. doi: 10.1177/1066896919879980. [Epub ahead of print]

PMID:
31612752
3.

Variational Bayesian methods for cognitive science.

Galdo M, Bahg G, Turner BM.

Psychol Methods. 2019 Oct 10. doi: 10.1037/met0000242. [Epub ahead of print]

PMID:
31599616
4.

Second-harmonic generation directionality is associated with neoadjuvant chemotherapy response in breast cancer core needle biopsies.

Desa DE, Bhanote M, Hill RL, Majeski JB, Buscaglia B, D'Aguiar M, Strawderman R, Hicks DG, Turner BM, Brown EB.

J Biomed Opt. 2019 Aug;24(8):1-9. doi: 10.1117/1.JBO.24.8.086503.

5.

Individual Differences in the Neural Dynamics of Response Inhibition.

Molloy MF, Bahg G, Lu ZL, Turner BM.

J Cogn Neurosci. 2019 Dec;31(12):1976-1996. doi: 10.1162/jocn_a_01458. Epub 2019 Aug 9.

PMID:
31397614
6.

Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26.

Turner BM, Gimenez-Sanders MA, Soukiazian A, Breaux AC, Skinner K, Shayne M, Soukiazian N, Ling M, Hicks DG.

Cancer Med. 2019 Aug;8(9):4176-4188. doi: 10.1002/cam4.2323. Epub 2019 Jun 14.

7.

Advances in techniques for imposing reciprocity in brain-behavior relations.

Turner BM, Palestro JJ, Miletić S, Forstmann BU.

Neurosci Biobehav Rev. 2019 Jul;102:327-336. doi: 10.1016/j.neubiorev.2019.04.018. Epub 2019 May 22. Review.

PMID:
31128445
8.

Toward a common representational framework for adaptation.

Turner BM.

Psychol Rev. 2019 Oct;126(5):660-692. doi: 10.1037/rev0000148. Epub 2019 Apr 11.

PMID:
30973248
9.

Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients.

Soukiazian A, Hicks DG, Turner BM.

Breast J. 2019 May;25(3):545-547. doi: 10.1111/tbj.13275. Epub 2019 Apr 10. No abstract available.

PMID:
30972823
10.

Bayesian statistics to test Bayes optimality.

Turner BM, McClelland JL, Busemeyer J.

Behav Brain Sci. 2018 Jan;41:e246. doi: 10.1017/S0140525X18001334.

PMID:
30767805
11.

Cognitive and Neural Bases of Multi-Attribute, Multi-Alternative, Value-based Decisions.

Busemeyer JR, Gluth S, Rieskamp J, Turner BM.

Trends Cogn Sci. 2019 Mar;23(3):251-263. doi: 10.1016/j.tics.2018.12.003. Epub 2019 Jan 7. Review.

PMID:
30630672
12.

Approximating Bayesian Inference through Model Simulation.

Turner BM, Van Zandt T.

Trends Cogn Sci. 2018 Sep;22(9):826-840. doi: 10.1016/j.tics.2018.06.003. Epub 2018 Aug 6. Review.

PMID:
30093313
13.

Some task demands induce collapsing bounds: Evidence from a behavioral analysis.

Palestro JJ, Weichart E, Sederberg PB, Turner BM.

Psychon Bull Rev. 2018 Aug;25(4):1225-1248. doi: 10.3758/s13423-018-1479-9.

PMID:
29845433
14.

On the Neural and Mechanistic Bases of Self-Control.

Turner BM, Rodriguez CA, Liu Q, Molloy MF, Hoogendijk M, McClure SM.

Cereb Cortex. 2019 Feb 1;29(2):732-750. doi: 10.1093/cercor/bhx355.

PMID:
29373633
15.

Outlook on deep neural networks in computational cognitive neuroscience.

Turner BM, Miletić S, Forstmann BU.

Neuroimage. 2018 Oct 15;180(Pt A):117-118. doi: 10.1016/j.neuroimage.2017.12.078. Epub 2017 Dec 30. No abstract available.

PMID:
29292134
16.

Competing theories of multialternative, multiattribute preferential choice.

Turner BM, Schley DR, Muller C, Tsetsos K.

Psychol Rev. 2018 Apr;125(3):329-362. doi: 10.1037/rev0000089. Epub 2017 Dec 21.

PMID:
29265855
17.

Factor analysis linking functions for simultaneously modeling neural and behavioral data.

Turner BM, Wang T, Merkle EC.

Neuroimage. 2017 Jun;153:28-48. doi: 10.1016/j.neuroimage.2017.03.044. Epub 2017 Mar 22.

PMID:
28341163
18.

Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.

Turner BM, Hicks DG.

Biotech Histochem. 2017;92(3):175-200. doi: 10.1080/10520295.2017.1290276. Epub 2017 Mar 20.

PMID:
28318327
19.

The dynamics of multimodal integration: The averaging diffusion model.

Turner BM, Gao J, Koenig S, Palfy D, L McClelland J.

Psychon Bull Rev. 2017 Dec;24(6):1819-1843. doi: 10.3758/s13423-017-1255-2.

PMID:
28275990
20.

Approaches to Analysis in Model-based Cognitive Neuroscience.

Turner BM, Forstmann BU, Love BC, Palmeri TJ, Van Maanen L.

J Math Psychol. 2017 Feb;76(B):65-79. doi: 10.1016/j.jmp.2016.01.001. Epub 2016 Feb 17.

21.

Model-based cognitive neuroscience.

Palmeri TJ, Love BC, Turner BM.

J Math Psychol. 2017 Feb;76(Pt B):59-64. doi: 10.1016/j.jmp.2016.10.010. Epub 2016 Nov 23.

22.

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.

Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, Miller DV, Armstrong DK, Connolly RM, Fetting JH, Miller RS, Park BH, Stearns V, Visvanathan K, Wolff AC, Cope L.

J Clin Oncol. 2016 Dec 20;34(36):4390-4397. Epub 2016 Oct 31.

23.

Protein kinase Msk1 physically and functionally interacts with the KMT2A/MLL1 methyltransferase complex and contributes to the regulation of multiple target genes.

Wiersma M, Bussiere M, Halsall JA, Turan N, Slany R, Turner BM, Nightingale KP.

Epigenetics Chromatin. 2016 Nov 11;9:52. eCollection 2016.

24.

Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success.

Halsall JA, Turner BM.

Bioessays. 2016 Nov;38(11):1102-1110. doi: 10.1002/bies.201600070. Epub 2016 Sep 22. Review.

25.

The anchor integration model: A descriptive model of anchoring effects.

Turner BM, Schley DR.

Cogn Psychol. 2016 Nov;90:1-47. doi: 10.1016/j.cogpsych.2016.07.003. Epub 2016 Aug 24.

PMID:
27567237
26.

Why more is better: Simultaneous modeling of EEG, fMRI, and behavioral data.

Turner BM, Rodriguez CA, Norcia TM, McClure SM, Steyvers M.

Neuroimage. 2016 Mar;128:96-115. doi: 10.1016/j.neuroimage.2015.12.030. Epub 2015 Dec 23.

PMID:
26723544
27.

Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response.

Halsall JA, Turan N, Wiersma M, Turner BM.

Epigenetics Chromatin. 2015 Sep 16;8:29. doi: 10.1186/s13072-015-0021-9. eCollection 2015.

28.

The neural basis of value accumulation in intertemporal choice.

Rodriguez CA, Turner BM, Van Zandt T, McClure SM.

Eur J Neurosci. 2015 Sep;42(5):2179-89. doi: 10.1111/ejn.12997. Epub 2015 Aug 13.

29.

Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score.

Turner BM, Skinner KA, Tang P, Jackson MC, Soukiazian N, Shayne M, Huston A, Ling M, Hicks DG.

Mod Pathol. 2015 Jul;28(7):921-31. doi: 10.1038/modpathol.2015.50. Epub 2015 May 1.

31.

Informing cognitive abstractions through neuroimaging: the neural drift diffusion model.

Turner BM, van Maanen L, Forstmann BU.

Psychol Rev. 2015 Apr;122(2):312-336. doi: 10.1037/a0038894.

PMID:
25844875
32.

Dosage compensation in mammals.

Brockdorff N, Turner BM.

Cold Spring Harb Perspect Biol. 2015 Mar 2;7(3):a019406. doi: 10.1101/cshperspect.a019406. Review.

33.

When the brain takes a break: a model-based analysis of mind wandering.

Mittner M, Boekel W, Tucker AM, Turner BM, Heathcote A, Forstmann BU.

J Neurosci. 2014 Dec 3;34(49):16286-95. doi: 10.1523/JNEUROSCI.2062-14.2014. Erratum in: J Neurosci. 2017 May 31;37(22):5587.

34.

Intertemporal choice as discounted value accumulation.

Rodriguez CA, Turner BM, McClure SM.

PLoS One. 2014 Feb 28;9(2):e90138. doi: 10.1371/journal.pone.0090138. eCollection 2014.

35.

Nucleosome signalling; an evolving concept.

Turner BM.

Biochim Biophys Acta. 2014 Aug;1839(8):623-6. doi: 10.1016/j.bbagrm.2014.01.001. Epub 2014 Jan 9. Review.

PMID:
24412235
36.

Hierarchical approximate Bayesian computation.

Turner BM, Van Zandt T.

Psychometrika. 2014 Apr;79(2):185-209. doi: 10.1007/s11336-013-9381-x. Epub 2013 Dec 3.

37.

A generalized, likelihood-free method for posterior estimation.

Turner BM, Sederberg PB.

Psychon Bull Rev. 2014 Apr;21(2):227-50. doi: 10.3758/s13423-013-0530-0. Review.

38.

Evaluating probabilistic forecasts with Bayesian signal detection models.

Steyvers M, Wallsten TS, Merkle EC, Turner BM.

Risk Anal. 2014 Mar;34(3):435-52. doi: 10.1111/risa.12127. Epub 2013 Oct 22.

PMID:
24147636
39.

A method for efficiently sampling from distributions with correlated dimensions.

Turner BM, Sederberg PB, Brown SD, Steyvers M.

Psychol Methods. 2013 Sep;18(3):368-84. doi: 10.1037/a0032222. Epub 2013 May 6.

40.

The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing.

Boudadi E, Stower H, Halsall JA, Rutledge CE, Leeb M, Wutz A, O'Neill LP, Nightingale KP, Turner BM.

Epigenetics Chromatin. 2013 May 1;6(1):11. doi: 10.1186/1756-8935-6-11.

41.

Likelihood-free Bayesian analysis of memory models.

Turner BM, Dennis S, Van Zandt T.

Psychol Rev. 2013 Jul;120(3):667-678. doi: 10.1037/a0032458. Epub 2013 Apr 15.

42.

A Bayesian framework for simultaneously modeling neural and behavioral data.

Turner BM, Forstmann BU, Wagenmakers EJ, Brown SD, Sederberg PB, Steyvers M.

Neuroimage. 2013 May 15;72:193-206. doi: 10.1016/j.neuroimage.2013.01.048. Epub 2013 Jan 28.

43.

Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.

Singh PK, Doig CL, Dhiman VK, Turner BM, Smiraglia DJ, Campbell MJ.

J Steroid Biochem Mol Biol. 2013 Jul;136:258-63. doi: 10.1016/j.jsbmb.2012.10.002. Epub 2012 Oct 23. Review.

44.

Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.

Doig CL, Singh PK, Dhiman VK, Thorne JL, Battaglia S, Sobolewski M, Maguire O, O'Neill LP, Turner BM, McCabe CJ, Smiraglia DJ, Campbell MJ.

Carcinogenesis. 2013 Feb;34(2):248-56. doi: 10.1093/carcin/bgs331. Epub 2012 Oct 20.

45.

Altered histone modifications in cancer.

Campbell MJ, Turner BM.

Adv Exp Med Biol. 2013;754:81-107. doi: 10.1007/978-1-4419-9967-2_4. Review.

PMID:
22956497
46.

A unified phylogeny-based nomenclature for histone variants.

Talbert PB, Ahmad K, Almouzni G, Ausió J, Berger F, Bhalla PL, Bonner WM, Cande WZ, Chadwick BP, Chan SW, Cross GA, Cui L, Dimitrov SI, Doenecke D, Eirin-López JM, Gorovsky MA, Hake SB, Hamkalo BA, Holec S, Jacobsen SE, Kamieniarz K, Khochbin S, Ladurner AG, Landsman D, Latham JA, Loppin B, Malik HS, Marzluff WF, Pehrson JR, Postberg J, Schneider R, Singh MB, Smith MM, Thompson E, Torres-Padilla ME, Tremethick DJ, Turner BM, Waterborg JH, Wollmann H, Yelagandula R, Zhu B, Henikoff S.

Epigenetics Chromatin. 2012 Jun 21;5:7. doi: 10.1186/1756-8935-5-7.

47.

The adjustable nucleosome: an epigenetic signaling module.

Turner BM.

Trends Genet. 2012 Sep;28(9):436-44. doi: 10.1016/j.tig.2012.04.003. Epub 2012 May 24. Review.

PMID:
22633123
48.

Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors.

Halsall J, Gupta V, O'Neill LP, Turner BM, Nightingale KP.

PLoS One. 2012;7(3):e33453. doi: 10.1371/journal.pone.0033453. Epub 2012 Mar 30.

49.

Epigenetic engineering: histone H3K9 acetylation is compatible with kinetochore structure and function.

Bergmann JH, Jakubsche JN, Martins NM, Kagansky A, Nakano M, Kimura H, Kelly DA, Turner BM, Masumoto H, Larionov V, Earnshaw WC.

J Cell Sci. 2012 Jan 15;125(Pt 2):411-21. doi: 10.1242/jcs.090639. Epub 2012 Feb 13.

50.

Supplemental Content

Loading ...
Support Center